MNTA Momenta Pharmaceuticals Inc.
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
- 13.83 P/E
- 13.13 P/S
- 2.87 P/B
- -2.193 EPS
- -146.29% Cash ROIC
- 11.20 Cash Ratio
- 0 / 0% Dividend
- 450,106.00 Avg. Vol.
- 51.59M Shares
- 582.5M Market Cap.
Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the in the characterization and process engineering of complex molecules. These complex molecules include proteins, polypeptides, and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). The company applies its technology for the development of generic versions of complex drug products, as well as for th...
Motley Fool - Nov 5, 2014
Momenta Pharmaceuticals Inc.: Momenta Pharmaceuticals Reports Third ... - The Wall Street Transcript
MarketWatch - Nov 6, 2014
MarketWatch - Oct 22, 2014
PR Newswire (press release) - Oct 17, 2014
PipelineReview.com (press release) - Oct 9, 2014
Techsonian (press release) - Nov 11, 2014
Fico News Media - Nov 10, 2014
Seeking Alpha (registration) - Nov 13, 2014
Property Mentor - Nov 14, 2014
WallStreet Scope - Oct 31, 2014